Among 13 m6A regulators, only METTL3, HNRNPC and RBM15 were upregulated in metastatic ACC samples, which suggested that these m6A DEGs may serve as oncogenes in ACC progression. The gene discussed is METTL3; the disease is adrenal cortex carcinoma.